National and Kapodistrian University of Athens
Ο ρόλος της κινάσης ΜΚ2 στην ανάπτυξη φλεγμονής και καρκίνου του εντέρου
Abstract
dc:descriptionMAPKAPK2 (MK2) is a direct downstream substrate of p38 and regulates pro-inflammatory cytokine production, while it is also involved in the regulation of the cell cycle and apoptosis, suggesting an important role in carcinogenesis. The role of MK2 in inflammation is the most extensively studied. It is mediated through the post-transcriptional control of pro-inflammatory cytokines, such as TNF and IL-6, and has been shown to play an important role in various inflammatory diseases in vivo. MK2 is also the main kinase that phosphorylates Hsp27, which mediates cytokine expression and has been further implicated in the regulation of cell proliferation, apoptosis and migration. Hsp27 is often found upregulated and phosphorylated in cancer and it has been associated with poor prognosis. MK2 has been proposed as a potential alternative target to p38 inhibition, as it could reproduce the beneficial effects of p38 inhibitors potentially sparing the accompanying side effects.The role of MK2 in cancer is not as well studied as in inflammation; in vivo data using MK2 knockout mice have shown that it plays an important role in the initiation and the early stages of chemically induced skin tumorigenesis in mice, mainly through the regulation of pro-inflammatory cytokine expression and the stabilization of the tumor suppressor protein p53. Recently, it was also shown that mice deficient in MK2 were resistant to the development of AOM/DSS-induced colitis-associated cancer, although the exact cellular and molecular mechanism underlying this phenotype remained unclear. In the present study, we have addressed the cell-specific pathophysiological role of MK2 in intestinal carcinogenesis. To investigate the cell-specific role of MK2 in intestinal carcinogenesis, we initially generated two new mouse strains, a complete and a conditional MK2 knockout mouse line, used two mouse models of intestinal carcinogenesis and performed bone-marrow transfers. We measured tumor number and size and assessed epithelial proliferation, apoptosis, inflammatory infiltration and angiogenesis in different time-points during disease progression. We also performed in vitro experiments to examine the response of primary intestinal mesenchymal cells lacking MK2 to different stimuli and co-cultures between epithelial organoids and mesenchymal cells to identify heterotypic interactions between different stroma populations. Finally, we used two chemical inhibitors of MK2 to assess the effect of pharmacological inhibition in intestinal tumorigenesis.We show that both genetic and chemical inhibition of MK2 was associated with reduced tumor growth, invasive potential and increased survival in the Apcmin/+ and colitis-associated cancer model. MK2-deficiency in Apcmin/+ led to deregulation of apoptosis and a significant reduction in epithelial proliferation and angiogenesis, without affecting inflammation in the intestine. Histopathological analysis during the course of the disease further revealed an important role of MK2 in tumor progression rather than initiation, as MK2 knockout mice developed comparable number of microadenomas during the initiation phase of the disease. Notably, bone-marrow transfers demonstrated that reduced tumorigenesis was not mediated by its well-described immunomodulatory roles in immune and inflammatory cells. Deletion of MK2 in intestinal mesenchymal cells (IMCs) led to both reduced tumor multiplicity and growth. Mechanistically, MK2 in IMCs was required for Hsp27 phosphorylation and the production of downstream tumorigenic effector molecules and for the growth and survival of co-cultured intestinal organoids, dominantly affecting epithelial proliferation, apoptosis and angiogenesis. Genetic ablation of MK2 in intestinal epithelial or endothelial cells was less effective in comparison to its complete deletion, leading to reduction of tumor size via modulation of epithelial apoptosis and angiogenesis-associated proliferation, respectively. Similar results were obtained in a model of colitis-associated carcinogenesis, indicating a mesenchymal-specific role for MK2 also in this model. Our findings demonstrate the central pathogenic role of mesenchymal-specific MK2/Hsp27 axis in tumorigenesis and highlight the value of mesenchymal MK2 inhibition in the treatment of cancer.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Henriques, Ana
Subjects
dc:subject × 6Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43586